Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 98
2012 437
2013 516
2014 672
2015 679
2016 722
2017 2058
2018 3320
2019 3294
2020 4146
2021 6623
2022 8714
2023 4869

Text availability

Article attribute

Article type

Publication date

Search Results

33,919 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: New therapeutic approaches for SARS-CoV-2/COVID-19.
Rodriguez-Morales AJ, Barbosa AN, Cimerman S. Rodriguez-Morales AJ, et al. Front Immunol. 2023 Aug 24;14:1276279. doi: 10.3389/fimmu.2023.1276279. eCollection 2023. Front Immunol. 2023. PMID: 37691938 Free PMC article. No abstract available.
Editorial: Immunological aspects of vaccine safety.
Vajdy M, Rath BA, Talaat KR. Vajdy M, et al. Front Immunol. 2023 Aug 18;14:1212148. doi: 10.3389/fimmu.2023.1212148. eCollection 2023. Front Immunol. 2023. PMID: 37662921 Free PMC article. No abstract available.
Cancer immunotherapies: advances and bottlenecks.
Rui R, Zhou L, He S. Rui R, et al. Front Immunol. 2023 Aug 24;14:1212476. doi: 10.3389/fimmu.2023.1212476. eCollection 2023. Front Immunol. 2023. PMID: 37691932 Free PMC article. Review.
Autoimmunity against laminin 332.
Patzelt S, Schmidt E. Patzelt S, et al. Front Immunol. 2023 Aug 10;14:1250115. doi: 10.3389/fimmu.2023.1250115. eCollection 2023. Front Immunol. 2023. PMID: 37638011 Free PMC article. Review.
Editorial: Methods in T cell biology: 2022.
Aguado E, Call ME. Aguado E, et al. Front Immunol. 2023 Aug 8;14:1266576. doi: 10.3389/fimmu.2023.1266576. eCollection 2023. Front Immunol. 2023. PMID: 37614241 Free PMC article. No abstract available.
Editorial: Targeting signalling pathways in inflammatory diseases.
Baig MS, Thurston TLM, Sharma R, Atre R, Saqib U, Khabiya R, Bharti S, Poh CL. Baig MS, et al. Front Immunol. 2023 Aug 1;14:1241440. doi: 10.3389/fimmu.2023.1241440. eCollection 2023. Front Immunol. 2023. PMID: 37593741 Free PMC article. No abstract available.
Cell-targeted vaccines: implications for adaptive immunity.
Ung T, Rutledge NS, Weiss AM, Esser-Kahn AP, Deak P. Ung T, et al. Front Immunol. 2023 Aug 16;14:1221008. doi: 10.3389/fimmu.2023.1221008. eCollection 2023. Front Immunol. 2023. PMID: 37662903 Free PMC article. Review.
Animal models for COVID-19 and tuberculosis.
Corleis B, Bastian M, Hoffmann D, Beer M, Dorhoi A. Corleis B, et al. Front Immunol. 2023 Aug 11;14:1223260. doi: 10.3389/fimmu.2023.1223260. eCollection 2023. Front Immunol. 2023. PMID: 37638020 Free PMC article. Review.
Peptide-based vaccine for cancer therapies.
Buonaguro L, Tagliamonte M. Buonaguro L, et al. Front Immunol. 2023 Aug 16;14:1210044. doi: 10.3389/fimmu.2023.1210044. eCollection 2023. Front Immunol. 2023. PMID: 37654484 Free PMC article. Review.
33,919 results
You have reached the last available page of results. Please see the User Guide for more information.